Antiproliferative effects of NKH477, a forskolin derivative, on cytokine profile in rat lung allografts

Journal of Heart and Lung Transplantation

Volumn 24, Issue 4, 2005, Pages 462-469

  Nakashima, Shinji ^a   Morikawa, Masayuki ^a   Komatsu, Kanshi ^a   Matsuura, Akihiro ^a,b   Sato, Noriyuki ^a   Abe, Tomio ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 (3 DIMETHYLAMINOPROPIONYL)FORSKOLIN; CYTOKINE; FORSKOLIN DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; THYMIDINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCISION; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MALE; MESENTERY LYMPH NODE; NONHUMAN; ORGAN DONOR; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; RAT; RECIPIENT; SPLEEN; SURVIVAL TIME; UPREGULATION;

EID: 15544371100     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.02.011     Document Type: Article

References (33)

1. Munoz E., Zubiaga A.M., Merrow M., Sauter N.P., Huber B.T. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation Role of camp in t cell proliferation. J Exp Med. 172:1990;95-103
2. Anastassiou E.D., Paliogianni F., Balow J.P., Yamada H., Boumpas D.T. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. J Immunol. 148:1992;2845-2852
3. Khan M.M., Tran A.C., Keaney K.M. Forskolin and prostaglandin E2 regulate the generation of human cytolytic T lymphocytes. Immunopharmacology. 19:1990;151-161
4. Bradley J.A., Mason D.W., Morris P.J. Evidence that rat renal allografts are rejected by cytotoxic T cells and not by nonspecific effectors. Transplantation. 39:1985;169-175
5. Hosono M., Takahira T., Fujita A., et al. Cardiovascular and adenylate cyclase stimulant properties of NKH477, a novel water-soluble forskolin derivative. J Cardiovasc Pharmacol. 19:1992;625-634
6. Fujita A., Takahira T., Hosono M., Nakamura K. Improvement of drug-induced cardiac failure by NKH477, a novel forskolin derivative, in the dog heart-lung preparation. Jpn J Pharmacol. 58:1992;375-381
7. Shafiq J., Suzuki S., Itoh T., Kuriyama H. Mechanisms of vasodilation induced by NKH477, a water-soluble forskolin derivative, in smooth muscle of the porcine coronary artery. Circ Res. 71:1992;70-81
8. Sandhu R., Thomas U., Diaz R.J., Wilson G.J. Effect of ischemic preconditioning of the myocardium on cAMP. Circ Res. 78:1996;137-147
9. Toya Y., Schwencke C., Ishikawa Y. Forskolin derivatives with increased selectivity for cardiac adenylyl cyclase. J Mol Cell Cardiol. 30:1998;97-108
10. Furukawa Y., Matsumori A., Hirozane T., et al. Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro. Clin Immunol Immunopathol. 79:1996;25-35
11. Marck K.W., Wildevuur C.R. Lung transplantation in the rat I. technique and survival. Ann Thorac Surg. 34:1982;74-80
12. Reis A., Giaid A., Serrick C., Shennib H. Improved outcome of rat lung transplantation with modification of the nonsuture external cuff technique. J Heart Lung Transplant. 14:1995;274-279
13. Prop J., Ehrie M.G., Crapo J.D., Nieuwenhuis P., Wildevuur C.R. Reimplantation response in isografted rat lungs Analysis of causal factors. J Thorac Cardiovasc Surg. 87:1984;702-711
14. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection Lung rejection study group. J Heart Lung Transplant. 15:1996;1-15
15. Kallio E.A., Koskinen P.K., Aavik E., Vaali K., Lemstom K.B. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat. J Clin Invest. 100:1997;2984-2994
16. Maulish A.E., Strong D.M. Lymphocyte proliferation. Rose N.R., Friedman H., Fahey J.L. Manual of clinical laboratory immunology. 3rd ed :1986;27481 American Society for Microbiology, Washington, DC
17. Prop J., Kuijpers K., Petersen A.H., Bartels H.L., Nieuwenhuis P., Wildevuur C.R. Why are lung allografts more vigorously rejected than hearts? J Heart Transplant. 4:1985;433-436
18. Prop J., Nieuwenhuis P., Wildevuur C.R. Lung allograft rejection in the rat. I. Accelerated rejection caused by graft lymphocytes. Transplantation. 40:1985;25-30
19. Vriens P.W., Nisco S.J., Hoyt E.G., et al. Tissue-specific differences in the establishment of tolerance Tolerogenic effects of lung allografts in rats. Transplantation. 57:1994;1795-1798
20. Mosmann T.R., Coffman R.L. Th1 and Th2 cells Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 7:1989;145-173
21. Nickerson P., Steurer W., Steiger J., Zheng X., Steele A.W., Strom T.B. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol. 6:1994;757-764
22. Ross D.J., Moudgil A., Bagga A., et al. Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage. J Heart Lung Transplant. 18:1999;627-636
23. Mattsson P., Zeevi A., Cai J., et al. Effect of aminoguanidine and cyclosporine on lung allograft rejection. Ann Thorac Surg. 62:1996;207-212
24. Francalancia N.A., Wang S.C., Thai N.L., et al. Graft cytokine mRNA activity in rat single lung transplants by reverse transcription-polymerase chain reaction Effect of cyclosporine. J Heart Lung Transplant. 11:1992;1041-1045
25. Egawa H., Martinez O.M., Quinn M.B., et al. Acute liver allograft rejection in the rat. An analysis of the immune response. Transplantation. 59:1995;97-102
26. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60-66
27. Krieger N.R., Most D., Bromberg J.S., et al. Coexistence of Th1- and Th2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance. Transplantation. 62:1996;1285-1292
28. Lang T., Krams S.M., Martinez O.M. Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. Transplantation. 62:1996;776-780
29. Strom T.B., Roy-Chaudhury P., Manfro R., et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol. 8:1996;688-693
30. Panina-Bordignon P., Mazzeo D., Lucia P.D., et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest. 100:1997;1513-1519
31. Bromberg J.S. IL-10 immunosuppression in transplantation. Curr Opin Immunol. 7:1995;639-643
32. Itano H., Mora B.N., Zhang W., et al. Lipid-mediated ex vivo gene transfer of viral interleukin 10 in rat lung allotransplantation. J Thorac Cardiovasc Surg. 122:2001;29-38
33. Mitruka S.N., Pham S.M., Zeevi A., et al. Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation. J Thorac Cardiovasc Surg. 115:1998;28-36